October 21, 2016 5:23 PM ET

Life Sciences Tools and Services

Company Overview of Catalent Pharma Solutions, Inc.

Company Overview

Catalent Pharma Solutions, Inc. provides development solutions and delivery technologies for drugs, biologics, and consumer health products. The company’s Development and Clinical Services segment offers manufacturing, packaging, storage, and inventory management services for drugs and biologics in clinical trials. This segment also provides analytical chemical and cell-based testing and scientific services; respiratory products formulation and manufacturing; regulatory consulting; and bioanalytical testing for biologic products. Its Oral Technologies segment offers oral delivery technologies, including formulation, development, and manufacturing services for the oral dose forms comprising p...

14 Schoolhouse Road

Somerset, NJ 08873

United States

8,300 Employees





Key Executives for Catalent Pharma Solutions, Inc.

Chief Executive Officer, President and Director
Age: 52
Chief Financial Officer, Principal Accounting Officer and Executive Vice President
Age: 49
Senior Vice President of Global Operations
Age: 54
President of Advanced Delivery Technologies
Age: 50
President of Catalent Asia Pacific
Compensation as of Fiscal Year 2016.

Catalent Pharma Solutions, Inc. Key Developments

Arch Biopartners, Inc. Engages Catalent Inhalation to Begin the Manufacturing Process for its Drug Ab569

Arch Biopartners, Inc. announced it has engaged Catalent Inhalation, a division of Catalent Pharma Solutions to begin the manufacturing process for its drug AB569 in preparation for the first human trials involving patients with antibiotic resistant lung infections. Catalent Inhalation will commence with initial stability and formulation studies, which are both important production milestones in preparing a pharmaceutical product for human trials and eventual drug approval by the U.S. Food and Drug Administration and other health authorities. Once the stability and formulation work is completed with positive results, Arch will engage Catalent Inhalation to manufacture a supply of AB569 that meets good manufacturing practice (GMP) standards to enable human trials to treat cystic fibrosis and chronic obstructive pulmonary disease patients with chronic bacterial lung infections.

Catalent Pharma Solutions Opens New Clinical Supply Facility in Kakegawa, Japan

Catalent Pharma Solutions has announced the opening of its clinical supply facility, located within its 200,000sqft cGMP site in Kakegawa, Japan. The site will serve the needs of both domestic and global clinical trial sponsors with services including secondary packaging and labeling, clinical storage, distribution, project management and clinical supply management, and will complement the capabilities of other Catalent facilities in the Asia-Pacific region.

Catalent Pharma Solutions to Invest $4.6 Million to Expand Singapore Clinical Supply Facility

Catalent Pharma Solutions has announced that it will invest $4.6 million to further expand its Singapore clinical supply facility by building new GMP space for secondary packaging, doubling its ambient storage space, and quadrupling cold storage capacity. Customer demand at the site has increased by 30% over last year, and this expansion, coupled with recently announced opening of a facility in Japan, will allow Catalent to better support multinational customers' growing trial's needs, while providing more flexible solutions for local customers in the region.

Similar Private Companies By Industry

Company Name Region
10X Genomics, Inc. United States
4G Clinical, Inc. United States
AAPharmaSyn LLC United States
Abiant, Inc. United States
aBioBot, Inc. United States

Recent Private Companies Transactions

September 13, 2016
Pharmatek Laboratories, Inc.
April 30, 2016
NephroGenex, Inc.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Catalent Pharma Solutions, Inc., please visit www.catalent.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.